IP Court restrained to sell and market a generic drug until the patent expiry
On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.
On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.
At present, the direction of medicine, such as telemedicine, becomes more and more known and the number of questions about the procedure of providing medical assistance using telemedicine is also growing.
The Ministry of Healthcare of the Russian Federation (the Minzdrav) has developed draft law aimed to improve regulation of drugs circulation, namely in respect of the determination of drugs interchangeability (the "Draft Law).
Lidings’ Managing Partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the 24th Russian Pharmaceutical Forum annually organized in Saint Petersburg by the Adam Smith Institute with Lidings’ support. The event will take place on May 15-16 traditionally hosted by one of the city’s central locations — Corinthia Hotel.
Partner of the Lidings’ Intellectual Property practice Boris Malakhov will take part in the All Russian Conference on Intellectual Property in Pharma Market: Protection of Rights and Court Practice in 2018. Organized by the Agency for Socio-Economic Development the event will take place in Moscow on April 23rd 2018 at the Balchug Kempinsky hotel.
On April 13, 2018 the draft law (hereinafter — the “Draft law”) imposing measures (countermeasures) in response to the hostile acts of the USA and (or) other foreign countries has been introduced to State Duma by both State Duma’s chairman and parliamentary leaders.
Lidings’ Managing partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the conference entitled Pharmaceuticals — 2018: Legal Aspects. The event organized by Pravo.ru will take place in Moscow on April 17th at the Metropol hotel.
Lidings law firm once again takes a leading position in the ranking of the most prominent legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper.
Reflected by the Pravo.ru’s Sympathy Rating — 2017 identifying the most prominent legal advisors in Russia based on the feedback of peers Lidings recognized as a leading firm for its expertise in employment law and pharmaceuticals and healthcare industry practice area. Individual and moreover exclusive recognition as the only recommended lawyer in this sphere, for a remarkable work for advising pharmaceutical companies in Russia, is given to Lidings’ Managing Partner, Head of the firm’s Pharmaceuticals and Healthcare industry practice, Andrey Zelenin.
Senior Associate of the Lidings’ Intellectual Property practice Boris Malakhov will take part in the Pharma & Biotech Patent Litigation Conference in Amsterdam on February 27-28th. The event is organized by the C5 Group, one of the world’s main conference providers.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.